Bristol-Myers Squibb Company (ETR:BRM)
42.22
-0.13 (-0.30%)
Dec 1, 2025, 9:04 AM CET
ETR:BRM Revenue
Bristol-Myers Squibb Company had revenue of $12.22B USD in the quarter ending September 30, 2025, with 2.77% growth. This brings the company's revenue in the last twelve months to $48.03B, up 1.26% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$48.03B
Revenue Growth
+1.26%
P/S Ratio
2.11
Revenue / Employee
$1.41M
Employees
34,100
Market Cap
86.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
| Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
| Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
| Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
| Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
| Dec 31, 2019 | 26.15B | 3.58B | 15.89% |
| Dec 31, 2018 | 22.56B | 1.79B | 8.59% |
| Dec 31, 2017 | 20.78B | 1.35B | 6.94% |
| Dec 31, 2016 | 19.43B | 2.87B | 17.31% |
| Dec 31, 2015 | 16.56B | 681.00M | 4.29% |
| Dec 31, 2014 | 15.88B | -506.00M | -3.09% |
| Dec 31, 2013 | 16.39B | -1.24B | -7.01% |
| Dec 31, 2012 | 17.62B | -3.62B | -17.05% |
| Dec 31, 2011 | 21.24B | 1.76B | 9.03% |
| Dec 31, 2010 | 19.48B | 676.00M | 3.59% |
| Dec 31, 2009 | 18.81B | 1.09B | 6.17% |
| Dec 31, 2008 | 17.72B | 2.10B | 13.43% |
| Dec 31, 2007 | 15.62B | -591.00M | -3.65% |
| Dec 31, 2006 | 16.21B | -2.40B | -12.88% |
| Dec 31, 2005 | 18.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Bristol-Myers Squibb Company News
- 6 days ago - Bristol Myers (BMY) Sees Stock Surge on Positive Drug Trial News - GuruFocus
- 6 days ago - Bristol Myers Pops On A 'Surprisingly Positive' Update From Key Rival Bayer - Investor's Business Daily
- 6 days ago - Validea Detailed Fundamental Analysis - BMY - Nasdaq
- 8 days ago - BMY Quantitative Stock Analysis - Nasdaq
- 9 days ago - Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Benzinga
- 9 days ago - Bristol-Myers Squibb: I See No Catalysts To Break Underperformance - Seeking Alpha
- 10 days ago - Sanofi (SNY) and Bristol Myers Squibb (BMY) Face Legal Action Over Plavix Marketing - GuruFocus
- 10 days ago - Bristol-Myers Squibb (BMY) Faces Legal Action Over Plavix Effectiveness Claims - GuruFocus